Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics Revenue

Marker Therapeutics had revenue of $3.32M in the twelve months ending March 31, 2024, down -12.23% year-over-year. Revenue in the quarter ending March 31, 2024 was $1.24M with 0.79% year-over-year growth. In the year 2023, Marker Therapeutics had annual revenue of $3.31M, a decrease of -5.76%.

• Revenue (ttm): $3.32M
• Revenue Growth: -12.23%
• P/S Ratio: 12.59
• Revenue / Employee: $415,107
• Employees: 8
• Market Cap: 41.92M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	3.31M	-202.41K	-5.76%
Dec 31, 2022	3.51M	2.27M	182.96%
Dec 31, 2021	1.24M	774.93K	166.01%
Dec 31, 2020	466.79K	253.59K	118.95%
Dec 31, 2019	213.19K	7.20K	3.50%
Dec 31, 2018	205.99K	22.93K	12.53%
Dec 31, 2017	183.06K	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.